History
Founded in 1980 by Mary Ann Liebert, Genetic Engineering and Biotechnology News is a publication reporting on the fields of gene editing, drug discovery and industry news. According to their
[about page](https://www.genengnews.com/about-gen/) “GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities.” [Read our profile on the United States government and media.](https://mediabiasfactcheck.com/united-states-media-profile/)
Funded by / Ownership
GEN is owned and published by Mary Ann Liebert, Inc., and revenue is derived from advertising and subscription fees.
Analysis / Bias
In review, GEN publishes news that is sourced from peer-reviewed publications such as this:
[Cancer-Killing T Cells Subdued, Kept “Stemmy,” by Potassium](https://www.genengnews.com/news/cancer-killing-t-cells-subdued-kept-stemmy-by-potassium/). Gen also covers industry news such as this: [Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration](https://www.genengnews.com/news/lilly-immunext-launch-up-to-605m-autoimmune-disease-collaboration/). There is generally little bias, and all information is sourced properly.
Failed Fact Checks
- None in the Last 5 years